TriMas Co. (NASDAQ:TRS) CFO Scott A. Mell Sells 2,218 Shares

TriMas Co. (NASDAQ:TRS - Get Free Report) CFO Scott A. Mell sold 2,218 shares of the company's stock in a transaction that occurred on Thursday, March 6th. The stock was sold at an average price of $22.54, for a total transaction of $49,993.72. Following the completion of the transaction, the chief financial officer now owns 26,288 shares in the company, valued at approximately $592,531.52. This represents a 7.78 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

TriMas Stock Down 1.4 %

TriMas stock traded down $0.34 during mid-day trading on Tuesday, reaching $23.81. 157,909 shares of the company's stock were exchanged, compared to its average volume of 275,288. The company has a quick ratio of 1.44, a current ratio of 2.83 and a debt-to-equity ratio of 0.60. TriMas Co. has a twelve month low of $19.33 and a twelve month high of $28.51. The company has a market cap of $966.28 million, a P/E ratio of 37.16 and a beta of 0.65. The company has a fifty day moving average of $23.58 and a 200-day moving average of $25.07.

TriMas Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, March 7th. Investors of record on Friday, February 28th were issued a $0.04 dividend. The ex-dividend date of this dividend was Friday, February 28th. This represents a $0.16 dividend on an annualized basis and a yield of 0.67%. TriMas's dividend payout ratio (DPR) is presently 27.12%.

Remove Ads

Institutional Investors Weigh In On TriMas

Several large investors have recently bought and sold shares of TRS. State of New Jersey Common Pension Fund D grew its position in shares of TriMas by 8.6% during the third quarter. State of New Jersey Common Pension Fund D now owns 79,822 shares of the industrial products company's stock worth $2,038,000 after buying an additional 6,344 shares in the last quarter. Impax Asset Management Group plc lifted its stake in TriMas by 216.4% in the third quarter. Impax Asset Management Group plc now owns 410,000 shares of the industrial products company's stock worth $10,467,000 after acquiring an additional 280,431 shares during the last quarter. Sasco Capital Inc. CT grew its holdings in TriMas by 26.6% during the 3rd quarter. Sasco Capital Inc. CT now owns 44,980 shares of the industrial products company's stock worth $1,148,000 after acquiring an additional 9,460 shares in the last quarter. Intech Investment Management LLC purchased a new stake in shares of TriMas in the 3rd quarter valued at approximately $269,000. Finally, Charles Schwab Investment Management Inc. raised its holdings in shares of TriMas by 0.9% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 582,846 shares of the industrial products company's stock valued at $14,880,000 after purchasing an additional 4,977 shares in the last quarter. Hedge funds and other institutional investors own 99.42% of the company's stock.

Analyst Upgrades and Downgrades

TRS has been the topic of several research analyst reports. StockNews.com upgraded TriMas from a "sell" rating to a "hold" rating in a report on Wednesday, November 13th. BWS Financial reaffirmed a "buy" rating and issued a $40.00 target price on shares of TriMas in a research report on Friday, February 28th.

About TriMas

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.